CERO — CERO THERAPEUTICS HLDGS INC COM NEW

Ownership history in Parallel Advisors, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in CERO THERAPEUTICS HLDGS INC COM NEW (CERO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q2)
Avg. % of fund
0.02%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 121,000 -99,000 -45.0% 0.01% $616K $5.09
2025 Q2 UNCHANGED 220,000 — 0% 0.04% $2.1M $9.63
2025 Q1 INITIATED 220,000 — — 0.00% $161K $14.60
% of Fund (quarterly)    CERO price (monthly, adj. close)

Other funds also holding CERO

As of 2025 Q3 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 0.02% FNY Investment Advisers, LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0% CITIGROUP INC 3Y 7Y 0.0% JONES FINANCIAL COMPANIES LLLP 3Y 7Y 0.0% UBS Group AG 3Y 7Y 0.0% BANK OF AMERICA CORP /DE/ 3Y 7Y 0.0%
← Back to Parallel Advisors, LLC Holdings